Introduction
Berberine, also known as huangliansu, is an isoquinoline alkaloid derived from the Chinese herb Huanglian, Huangbai and other plants. It has multiple pharmacological actions, such as antibacterial activity and anti-inflammatory effects, and is used in the treatment of diarrhea and other digestive disorders [1] . Berberine has been found to protect the gastric mucosa and inhibit gastric ulcers [2] , but the pharmacological mechanisms for the protective effect of berberine are not clear. Accumulating evidence from both animal and human studies indicates that nitric oxide (NO) plays a key role in normal wound repair. The beneficial effects of NO on wound repair may be attributed to its functional influences on angiogenesis and inflammation [3] . A recent study demonstrated that NO generated from endothelial nitric oxide synthase (eNOS) played an important role in gastric ulcer formation and gastric healing [4] . However, NO generated from inducible nitric oxide synthase (iNOS) participates in ulcer formation through the production of peroxide free radicals and their cytotoxic action [5] . At the same time, it was reported that berberine could induce the thoracic aorta of rats to release endothelial NO [6] , and 13-methylberberine and 13-ethylberberine reduced the production of NO and the expression of iNOS protein in a concentration-dependent manner in lipopolysaccharide (LPS)-stimulated macrophages [7] . We therefore inferred that it was possible for berberine to protect the gastric mucosa and accelerate the healing of peptic ulcers through the NO pathway. In the present study, we
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Aim: To investigate the protective effects of berberine on ethanol-induced gastric ulcer in mice. Methods: Gastric ulcers were induced by oral ingestion of ethanol. Nitric oxide (NO) content was measured, and mRNA expression of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) were analyzed by reverse transcription-polymerase chain reaction (RT-PCR).
Results:
The ulcer index (UI) at 1 h, 2 h, 3 h and 6 h after oral administration of ethanol was 23.8±1.4, 23.3±2.2, 22.3±1.2 and 20.8±1.1, respectively. The UI in the berberine-treated groups (5 mg/kg and 50 mg/kg) was less than the control group. The content of NO in the control group was 73.3±7.3 µL/L, 94.0±9.2 µL/L, 109.6± 6.4 µL/L and 138.2±10.2 µL/L in gastric juice and 5.8±1.1 µmol/g protein, 8.3± 1.1 µmol/g protein, 9.8±1.1 µmol/g protein and 11.9±1.2 µmol/g protein in gastric tissue at 1 h, 2 h, 3 h and 6 h, respectively, after the oral administration of ethanol. The content of NO in the berberine-treated groups (5 mg/kg and 50 mg/kg) was higher than the control group at 1 h after the oral administration of ethanol (P<0.05), and was lower at 6 h (P<0.05). Analysis by RT-PCR showed that expression of eNOS was inhibited but iNOS expression was enhanced by ethanol. However, the expression of eNOS could be enhanced and iNOS expression could be inhibited by berberine (P<0.01). Conclusion: Berberine could significantly protect gastric mucosa from damage by ethanol. This effect may be related to the increased expression of eNOS mRNA and inhibited expression of iNOS mRNA.
attempted to investigate whether the protective effect of berberine on gastric mucosa was related to NO and nitric oxide synthase (NOS). Induction of gastric ulcer Gastric ulcers were produced by oral administration of ethanol 24 h after starvation. Each of the mice was given 0.1 mL ethanol (100%, anhydrous alcohol).
Materials and methods

Drugs and reagents
Drugs treatments and measurement of ulcer size Animals were divided into 3 groups of 24 mice each. Group I received saline at a dose of 0.1 mL/kg (ip) and served as the control group. Group II received berberine at a dose of 5 mg/kg (ip) while group III received berberine at a dose of 50 mg/kg (ip).
Drugs were given 30 min before the oral administration of ethanol. The mice were killed by cervical dislocation 1 h, 2 h, 3 h and 6 h after oral administration of ethanol, and the gastric juice was sucked from the stomach before the stomach was removed. It was then opened along the greater curvature and the mucosa of the glandular portion of the stomach was rinsed gently with saline. Macroscopic damage was assessed and the number of ulcers, ulcer severity and ulcer index (UI) were recorded. Because each mouse had many lesions or ulcers and most gastric mucosal lesions were punctate or linear, each ulcer was graded according to severity using a scale of 1-4, as follows: 1, punctate ulcer; 2, linear ulcer of length ≤2 mm; 3, linear ulcer of length 2 mm-4 mm; and 4, linear ulcer of length ≥4 mm. The UI was calculated by summing the total number of ulcers, as described previously [8, 9] . The gastric tissues were stored at -70 °C until biochemical analysis.
Measurement of nitric oxide The content of nitric oxide in the gastric juice and gastric tissue was measured through the method of nitric acid reductase, and the operational processes were carried out strictly in accordance with the NO kit instructions.
Reverse-transcription polymerase chain reaction for the detection of eNOS and iNOS mRNA The stomachs were removed from the saline-treated (0.1 mL/kg) and berberinetreated (50 mg/kg) groups both before and after ulcer induction (1 h, 3 h and 6 h) for the determination of eNOS and iNOS mRNA expression by reverse transcription-polymerase chain reaction (RT-PCR) using specific primers. Total RNA was isolated from gastric tissues using Trizol reagent (Gibco BRL, Gathersburg, MD, USA). First-strand cDNA was synthesized from 5 µg of total cellular RNA using oligo-(dt) 20 primers with the thermoscript RT-PCR system (Gibco BRL). PCR cycles were carried out for amplification of eNOS, iNOS and β-actin cDNA using a thermal cycler (Perkin-Elmer Corporation 850 Lincoln Centre Drive, Foster City, California, USA) and oligonucleotides (Boya, Shanghai, China). The primers for eNOS were 5'-TTC CGG CTG CCA CCT GAT CCT AA-3' (sense) and 5'-AAC ATA TGT CCT TGC TCA AGG CA-3' (antisense) [10] . The β-actin primer sequences for iNOS were 5'-CGG GCA TTG CTC CCT TCC GAA AT-3'(sense) and 5'-CTT CAT GAT AAC GTT TCT GGC TCT-3' (antisense) [11] . The oligonucleotide primer sequences for β-actin were 5'-TCA CCC ACA CTG TGC CCA TCT ACG A-3' (sense) and 5'-GGA TGC CAC AGG ATT CCA TAC CCA-3' (antisense). The number of PCR cycles was adjusted carefully to avoid saturation of the amplification system. In the RT step, the cellular mRNAs were reverse-transcribed into a "library" of cDNAs. This cDNA library was then used for the analysis of various genes in the PCR step. Briefly, total RNA (2.5 µg) from each of the tissues was reverse transcribed into singlestranded cDNA in a 20-µL reaction mixture containing: 4 µL 5' buffer, 20 IU ribonuclease inhibitor, 10 mmol/L dNTP, 0.5 µg oligo-(dt) 20 primer, 20 IU RNasin and 200 IU M-MLV reverse transcriptase. After incubation for 1 h at 42 °C, the RT mixture was incubated at 70 °C for 10 min to inactivate the reverse transcriptase. PCR was then carried out using 5 µL cDNA in a final reaction volume of 50 µL. The assay mix contained 50 mmol/L KCl, 10 mmol/L Tris-HCl (pH 8.3), 1.5 mmol/L MgCl 2 , 0.2 mmol/L dNTP, 1 mmol/L of the respective primers and 1.5 IU of Taq DNA polymerase. The PCR cycling program was set for 1 cycle of pre-denaturation at 94 °C for 1 min, and then 35 cycles at 94 °C for 30 s, 55 °C for 30 s, 72 °C for 1 min, followed by 1 cycle at 72 °C for 5 min. PCR products were visualized by UV illumination after electrophoresis on a 2% agarose gel containing 0.5 µL ethidium bromide. The location of a predicted product was confirmed using a 100 bp DNA ladder (Gibco BRL) as a standard size marker. The gel photographs were scanned with a computerized densitometer (SYNGENE, London, Britain). The signals for eNOS and iNOS mRNA were standardized against the β-actin signal for each sample and the results are expressed as eNOS and iNOS mRNA/β-actin mRNA ratio.
Statistical analysis All of the data were expressed as mean±SD and the analysis was carried out using the t-test. Values of P < 0.05 were considered statistically significant.
Results
Effects of berberine on ethanol-induced gastric lesions
The UI of ethanol-induced gastric lesions are shown in Figures 1 and 2 . In the control group, the UI at 1 h, 2 h, 3 h and 6 h after oral administration of ethanol averaged 23.8± 1.4, 23.3±2.2, 22.3±1.2 and 20.8±1.1, respectively. The UI in the berberine-treated groups (5 mg/kg and 50 mg/kg) were less than the control group and this effect was time-dependent (P< 0.05 and P<0.01, respectively).
Change in nitric oxide content with the time The content of NO in gastric tissue and gastric juice is shown in Table 1 . In the control group, the content of NO in gastric juice at 1 h, 2 h, 3 h and 6 h after oral administration of ethanol was 73.3 ±7.3 µL/L, 94.0±9.2 µL/L, 109.6±6.4 µL/L and 138.2±10.2 µL/L, respectively, while the NO content in gastric tissue averaged 5.8±1.1 µmol/g protein, 8 .3±1.1 µmol/g protein, 9.8±1.1 µmol/g protein and 11.9±1.2 µmol/g protein, respectively. However, in both gastric tissue and gastric juice the content of NO in the berberine-treated groups (5 mg/kg and 50 mg/kg) was higher than that in the control group at 1 h after oral administration of ethanol (P<0.05, P<0.01), but lower at 6 h after oral administration of ethanol (P<0.05, P<0.01).
Expression of eNOS and iNOS mRNA Expression of iNOS and eNOS mRNA is shown in Figures 3 and 4 . In the base statement the mRNA of eNOS could be expressed while that of iNOS could almost not be expressed. In the control group the expression of eNOS was inhibited and iNOS was enhanced by ethanol, while in the berberine-treated groups the expression of eNOS could be enhanced and iNOS could be inhibited.
Discussion
Nitric oxide plays an important role in the host defense and inflammatory response [12, 13] . It also plays an important role in the mechanism of gastric mucosal protection and injury induced by pressure, ethanol, stress and endo toxins [14] [15] [16] [17] . Endogenous NO has a dual action in the gastrointestinal tract: protective effects by constitutive nitric oxide synthase (cNOS)/NO and proulcerogenic effects by iNOS/NO [8] . cNOS lies in gastric endotheliocytes in the gastric tissue, also called eNOS [18] . NO derived from eNOS is a pivotal mediator to accelerate gastric ulcer healing; it maintains the integrity of the gastric epithelium, regulates gastric mucosal blood flow, and stimulates gastric mucus secretion and synthesis [19] . On the other hand, NO stimulates the release of vasoactive intestinal peptide (VIP) in gastric tissue and increases the concentration of cGMP [20] . NO/cGMP plays a central role in producing relaxation of mouse gastric fundus smooth muscle, and cGMP protects gastric parietal cells from ethanol-induced cytotoxicity, implicating a basolateral Cl -channel in the plasma membrane or that pepsinogen secretion stimulated by a Ca 2+ -mediated agonist is modulated by a NO/cGMP pathway [8] . The results of the present study have shown that the content of NO in tissue from the berberinetreated group was higher than control group at 1 h after oral administration of ethanol, and further study has shown that expression of eNOS is higher. Therefore, we might conclude that berberine can increase NO production through improving eNOS mRNA expression. The effect of berberine on NO formation in the vascular system was also demonstrated [6, 21] . High expression of iNOS was found in ulcer tissue of the control group at 3 h and 6 h after ulcer induction. A similar phenomenon was also found by Peng et al [22] . Large amounts of NO synthesized from the inducible isoform have been implicated in tissue injury in the gut during inflammatory reactions [23] . Guo et al [24] also reported that high expression and activity of iNOS were found to coincide with severe inflammation in ulcer tissue. It is known that induction of high-output iNOS usually occurs in an oxidative environment, and thus high levels of NO have the opportunity to react with superoxide anion (O 2 -) leading to peroxynitrite (ONOO -) formation and cell toxicity, protein tyrosine nitration, hydroxyl radical production and tissue damage [24, 25] . The results of the present study have shown that iNOS is under low-expression conditions at all times in the berberine-treated groups, as the content of NO had no peak and it was kept at a relatively steady level. This demonstrated that berberine might decrease NO production through inhibition of iNOS expression in the gastric ulcer tissue, prevent the abundant release of NO that aggravates gastric mucosal injury and, ultimately, improve the healing of ulcers. The study of Lee et al [7] also showed that 13-methyberine and 13-ethyberberine both inhibited iNOS expression in LPS-stimulated macrophages. In conclusion, the protective effect of berberine results in an increase in eNOS mRNA expression, which inhibits the iNOS mRNA expression process.
